OPTIFLEX®

OPTIFLEX® is an advanced AI-driven platform designed to optimize and streamline the discovery of novel drug candidates. By precisely analyzing and enhancing key indicators, such as physicochemical and pharmacokinetic properties, through a multidimensional evaluation system, OPTIFLEX® accelerates the identification of the most promising lead compounds and development candidates.

OPTIFLEX®-SM

• Definition
  A cutting-edge technology designed to efficiently and rapidly identify drug candidates based on their physicochemical and pharmacokinetic properties.
• Principles
  • Evaluates and optimizes key indicators using a multidimensional scoring system that applies weighted values.
  • Accelerates the identification of optimal lead compounds and development candidates.
• Impact and Advantages
  • Enables faster and more efficient drug candidate discovery compared to traditional methods.
  • Significantly improves success rates in the early stages of drug development.

OPTIFLEX®-TPD

• Definition
  A state-of-the-art platform for developing drugs based on Targeted Protein Degradation (TPD).
• Principles
  • Utilizes a library of E3 ligase binder-linker conjugates to efficiently synthesize drug candidates.
  • Optimizes candidates with protein degradation functionality to rapidly identify viable development candidates.
  • Employs Armadillation Technology to predict cell membrane permeability of TPD molecules based on their 3D structure.
• Impact and Advantages
  • Offers innovative solutions for "undruggable proteins" that cannot be targeted via traditional approaches.
  • Significantly reduces drug development timelines and enables the discovery of effective treatments for challenging diseases.